Stock Groups

Don’t panic, and start working on your buy list

[ad_1]

Jim Cramer

Scott Mlyn | CNBC

This article was first sent to Jim Cramer’s CNBC Investing Club members. Get the latest updates directly to your email subscribe here.)

The markets are selling off sharply Friday on news of a heavily mutated COVID-19 variant detected in South Africa that could put the global recovery at risk, and like everyone else right now we don’t know enough about the new variant.

Today’s economic uncertainties and travel restrictions make it a great time to review the names of those companies that did well at the peak of the pandemic.

Possible buy list — essential retail

Possible buy list — testing and treatment

Another reason for people to test positive for COVID-19 is that a new variation has been developed. Abbot Laboratories (ABT)Rapid home test results that are affordable and of high quality. Eli Lilly (LLY)Another name we like for healthcare is Lilly’s antibody cocktail. However, it is not known if Lilly’s cocktail can be effective in treating this variant.

Although we would not chase these stocks if the stock is up, we are happy to take a look at any shares that fall below 2%.

Stop playing the “stay-at-home” game

We want to make one thing clear about the list: these investments aren’t solely COVID-19-based. This is not the time to be a stay-at home mom. Instead we have highlighted stocks which will benefit from the return of pandemic behavior.

This list includes market share winners and companies that have attractive growth opportunities and pipeline potential, as well as favorable initiatives specific to the company.

These stocks, with or without Covid, are what we love.

Possible buy list — strong balance sheets

Other than specific pandemic winners we will be focusing our attention on companies that have strong balance sheets, steady share repurchase programs, and healthy dividend payments. All three of these companies are able to tolerate and support volatile markets. Investors need to be ready for volatility over the next few weeks.

We are currently looking into a new concept that’s not part of the Charitable Trust. Chevron (CVX). This oil company has an impressive dividend, with a yield of 5%. It also offers a steady buyback, which could increase next year. At $70/barrel, they have plenty of earnings and cash flow. Although we are not allowed to trade CVX until Monday, it’s an intriguing idea that will change as the prices rise.

Lower rates have been a major problem for banks today, however this group has the right profile. Morgan Stanley (MS)And Wells Fargo (WFC)The two Charitable Trust stocks that we have are well-capitalized and offer huge repurchase options. Because we recently bought Morgan Stanley stock at the same price as last Friday and Wells Fargo has a large position with an average cost of $33, we aren’t looking to buy these stocks at their current levels.

If Morgan Stanley falls below the price of our purchase (e.g. $93-$94), which would be where the dividend yield is 3%, we’ll likely consider buying shares from them next.

Here’s what we want to stay clear of

The group we think is just too hard to buy right now are the ones that need cross-border activity and are tied to travel & entertainment. Stocks are like Boeing (BA), Wynn Resorts (WYNN)And even more Disney (DIS)It is despite the fact that Disney+ may see a boost in popularity if more people are inclined to live at home. These are downright awful, and no one panicked. It is possible that the variant with new features could work out. Sometimes, it is best just to relax. That’s exactly what we have done with this group.

End result

[ad_2]